Proliferating cell nuclear antigen index and nm23 expression in osteosarcoma in relation to disease- free survival and tumor grade.
Unal
Vuslat S
VS
Orthopedics and Traumatology Clinic, Ankara NumuneTraining and Research Hospital, Faculty of Medicine, Hacettepe University, Ankara, Turkey. vuslatsema@yahoo.com
Ayhan
Ayse
A
Tokgozoglu
Mazhar A
MA
D000293:Adolescent; D000328:Adult; D014408:Biomarkers, Tumor / Q000097:blood; D001707:Biopsy, Needle; D001859:Bone Neoplasms / Q000401:mortality* / Q000473:pathology* / Q000503:physiopathology; D002648:Child; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D054778:NM23 Nucleoside Diphosphate Kinases; D009361:Neoplasm Invasiveness / Q000473:pathology; D009367:Neoplasm Staging; D009701:Nucleoside-Diphosphate Kinase / Q000097:blood*; D012516:Osteosarcoma / Q000401:mortality* / Q000473:pathology* / Q000503:physiopathology; D011379:Prognosis; D018809:Proliferating Cell Nuclear Antigen / Q000097:blood*; D012680:Sensitivity and Specificity; D016019:Survival Analysis; D046509:Tissue Culture Techniques
D014408:Biomarkers, Tumor; D054778:NM23 Nucleoside Diphosphate Kinases; D018809:Proliferating Cell Nuclear Antigen; C517938:NME1 protein, human; D009701:Nucleoside-Diphosphate Kinase